$226.69−$2.60 (-1.13%)as of market close, Jul 24, 2026
CRL — Charles River Laboratories stock price, chart and key statistics
Key stats
Price data
- Price
- $226.69
- Change YTD
- +11.99%
- Next earnings
- Aug 5, 2026 · Before open
- Market cap
- 10.9B
- Enterprise value
- 12.4B
- Shares outstanding
- 48.2M
- 52W low
- $144.26
- 52W high
- $238.85
- From 52W high
- -5.09%
- From 52W low
- +57.14%
- 52W range
- 87%
- Beta
- 1.40
Volume
- Rel volume
- 0.79×
- 30D volume
- 832.4K
- 30D $ vol
- 178.9M
Fundamentals
- Sales (ttm)
- 4B
- Sales/share
- $83.60
- EPS (ttm)
- -$3.77
- FCF (ttm)
- 391.3M
- FCF/share
- $8.12
- Book value/share
- $61.05
- Net margin
- -4.59%
- ROE
- -6.28%
- ROA
- -2.39%
- Debt / equity
- 0.55×
- Current ratio
- 1.36
Growth (CAGR, ttm) · 10Y
- Sales
- +11.16%
- Net income
- n/a
- FCF
- +3.38%
- Shares
- +0.21%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- n/a
- Sales/share
- +10.93%
- FCF/share
- +3.17%
- Book value/share
- +13.95%
- Price
- +10.07%
- Total return
- +10.07%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- Fwd P/E
- 18.3×
- P/S (ttm)
- 2.7×
- P/B (mrq)
- 3.7×
- P/FCF (ttm)
- 27.9×
- EV/EBITDA (fy)
- 28.8×
- EV/Sales (ttm)
- 3.1×
- FCF yield (ttm)
- 3.58%
- Dividend yield (fwd)
- 0.53%
- Dividend/share (fwd)
- $1.20
- Buyback yield (ttm)
- 1.98%
- Shareholder yield (ttm)
- 1.98%
Vs own 10Y history
- P/E
- 97th
- P/S
- 50th
- P/B
- 33rd
- P/FCF
- 69th
Bar = where today's multiple sits in CRL's own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance
1D
-1.13%
1W
+1.04%
1M
+12.17%
3M
+35.14%
YTD
+11.99%
1Y
+34.97%
5Y
-41.04%
Financial statements
Open full CRL financials →Related Healthcare
1MCharles River Laboratories (CRL) trades at $226.69 with a live price and an interactive chart covering 26+ years of daily price history, plus key valuation metrics. ChartRow also publishes CRL's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full CRL financial statements →